Budesonide Inhalation Suspension is a fine particle suspension that forms a white or off-white suspension when shaken after settling, with budesonide as the primary component. It is indicated for the treatment of bronchial asthma and can be used as an alternative or to reduce oral steroid therapy. It is recommended to use Budesonide Inhalation Suspension when other methods of steroid administration are unsuitable. The initial dose, dose during severe asthma episodes, or when reducing oral corticosteroids is: 1-2 mg per dose, twice daily for adults; 0.5-1 mg per dose, twice daily for children. The maintenance dose should be individualized, aiming for the lowest dose that keeps the patient symptom-free. The recommended maintenance dose is: 0.5-1 mg per dose, twice daily for adults; 0.25-0.5 mg per dose, twice daily for children.